Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Medpace Holdings (NASDAQ:MEDP) through any online brokerage.
Other companies in Medpace Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Illumina Inc (NASDAQ:ILMN).
Medpace Holdings has a consensus price target of $520.63.
The stock price for Medpace Holdings (NASDAQ: MEDP) is $599.47 last updated October 2, 2026 at 4:39 PM EDT.
There are no upcoming dividends for Medpace Holdings.
Medpace Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Medpace Holdings.
Medpace Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.